These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 19438592)

  • 21. Cutting edge: profile of chemokine receptor expression on human plasma cells accounts for their efficient recruitment to target tissues.
    Nakayama T; Hieshima K; Izawa D; Tatsumi Y; Kanamaru A; Yoshie O
    J Immunol; 2003 Feb; 170(3):1136-40. PubMed ID: 12538668
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of the CXCL12/CXCR4 and CXCL16/CXCR6 axes in cervical intraepithelial neoplasia and cervical cancer.
    Huang Y; Zhang J; Cui ZM; Zhao J; Zheng Y
    Chin J Cancer; 2013 May; 32(5):289-96. PubMed ID: 22958742
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CXCL16/CXCR6 axis promotes bleomycin-induced fibrotic process in MRC-5 cells via the PI3K/AKT/FOXO3a pathway.
    Ma Z; Yu R; Zhu Q; Sun L; Jian L; Wang X; Zhao J; Li C; Liu X
    Int Immunopharmacol; 2020 Apr; 81():106035. PubMed ID: 31753588
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CC chemokine ligand 17 in periodontal diseases: expression in diseased tissues and production by human gingival fibroblasts.
    Hosokawa Y; Hosokawa I; Ozaki K; Nakae H; Matsuo T
    J Periodontal Res; 2008 Aug; 43(4):471-7. PubMed ID: 18557811
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human trophoblasts recruited T lymphocytes and monocytes into decidua by secretion of chemokine CXCL16 and interaction with CXCR6 in the first-trimester pregnancy.
    Huang Y; Zhu XY; Du MR; Li DJ
    J Immunol; 2008 Feb; 180(4):2367-75. PubMed ID: 18250446
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Role of CXCL16/CXCR6 axis in the metastasis of human prostate cancer].
    Zhou WH; Hu WD; Wu ZQ; Zheng XM; Wang BC
    Zhonghua Yi Xue Za Zhi; 2010 Apr; 90(14):947-51. PubMed ID: 20646641
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation of the CXCL16/CXCR6 Pathway by Inflammation Contributes to Atherosclerosis in Patients with End-stage Renal Disease.
    Hu ZB; Chen Y; Gong YX; Gao M; Zhang Y; Wang GH; Tang RN; Liu H; Liu BC; Ma KL
    Int J Med Sci; 2016; 13(11):858-867. PubMed ID: 27877078
    [No Abstract]   [Full Text] [Related]  

  • 28. CXCR6 is expressed in human prostate cancer in vivo and is involved in the in vitro invasion of PC3 and LNCap cells.
    Hu W; Zhen X; Xiong B; Wang B; Zhang W; Zhou W
    Cancer Sci; 2008 Jul; 99(7):1362-9. PubMed ID: 18452560
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Distribution and kinetics of SR-PSOX/CXCL16 and CXCR6 expression on human dendritic cell subsets and CD4+ T cells.
    Tabata S; Kadowaki N; Kitawaki T; Shimaoka T; Yonehara S; Yoshie O; Uchiyama T
    J Leukoc Biol; 2005 May; 77(5):777-86. PubMed ID: 15703197
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The CXCL16 A181V mutation selectively inhibits monocyte adhesion to CXCR6 but is not associated with human coronary heart disease.
    Petit SJ; Wise EL; Chambers JC; Sehmi J; Chayen NE; Kooner JS; Pease JE
    Arterioscler Thromb Vasc Biol; 2011 Apr; 31(4):914-20. PubMed ID: 21233446
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasmacytoid dendritic cell response to CpG ODN correlates with CXCL16 expression and is inhibited by ox-LDL.
    Gursel M; Klinman DM; Gursel I
    Mediators Inflamm; 2013; 2013():312590. PubMed ID: 24302814
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overexpression of CXCL16 and its receptor CXCR6/Bonzo promotes growth of human schwannomas.
    Held-Feindt J; Rehmke B; Mentlein R; Hattermann K; Knerlich F; Hugo HH; Ludwig A; Mehdorn HM
    Glia; 2008 May; 56(7):764-74. PubMed ID: 18293410
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression and potential function of the CXC chemokine CXCL16 in pancreatic ductal adenocarcinoma.
    Wente MN; Gaida MM; Mayer C; Michalski CW; Haag N; Giese T; Felix K; Bergmann F; Giese NA; Friess H
    Int J Oncol; 2008 Aug; 33(2):297-308. PubMed ID: 18636150
    [TBL] [Abstract][Full Text] [Related]  

  • 34. "Inverse signaling" of the transmembrane chemokine CXCL16 contributes to proliferative and anti-apoptotic effects in cultured human meningioma cells.
    Hattermann K; Bartsch K; Gebhardt HH; Mehdorn HM; Synowitz M; Schmitt AD; Mentlein R; Held-Feindt J
    Cell Commun Signal; 2016 Oct; 14(1):26. PubMed ID: 27784296
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression and localization of CXCL16 and CXCR6 in ovarian endometriotic tissues.
    Manabe S; Iwase A; Goto M; Kobayashi H; Takikawa S; Nagatomo Y; Nakahara T; Bayasula ; Nakamura T; Hirokawa W; Kikkawa F
    Arch Gynecol Obstet; 2011 Dec; 284(6):1567-72. PubMed ID: 21773780
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The CXCL16-CXCR6 chemokine axis in glial tumors.
    Hattermann K; Held-Feindt J; Ludwig A; Mentlein R
    J Neuroimmunol; 2013 Jul; 260(1-2):47-54. PubMed ID: 23628207
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression cloning of the STRL33/BONZO/TYMSTRligand reveals elements of CC, CXC, and CX3C chemokines.
    Wilbanks A; Zondlo SC; Murphy K; Mak S; Soler D; Langdon P; Andrew DP; Wu L; Briskin M
    J Immunol; 2001 Apr; 166(8):5145-54. PubMed ID: 11290797
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Chemokine Receptor CXCR6 Evokes Reverse Signaling via the Transmembrane Chemokine CXCL16.
    Adamski V; Mentlein R; Lucius R; Synowitz M; Held-Feindt J; Hattermann K
    Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28698473
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The prognostic significance of CXCL16 and its receptor C-X-C chemokine receptor 6 in prostate cancer.
    Richardsen E; Ness N; Melbø-Jørgensen C; Johannesen C; Grindstad T; Nordbakken C; Al-Saad S; Andersen S; Dønnem T; Nordby Y; Bremnes RM; Busund LT
    Am J Pathol; 2015 Oct; 185(10):2722-30. PubMed ID: 26272362
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of the CXCR6/CXCL16 axis in autoimmune diseases.
    Bao N; Fu B; Zhong X; Jia S; Ren Z; Wang H; Wang W; Shi H; Li J; Ge F; Chang Q; Gong Y; Liu W; Qiu F; Xu S; Li T
    Int Immunopharmacol; 2023 Aug; 121():110530. PubMed ID: 37348231
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.